3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)-
- Product Name
- 3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)-
- CAS No.
- 2565656-70-2
- Chemical Name
- 3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)-
- Synonyms
- LY3473329;Muvalaplin;(2S,2'S,2''S)-3,3',3''-((Nitrilotris(methylene))tris(benzene-3,1-diyl))tris(2-((R)-pyrrolidin-3-yl)propanoic acid);3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)-
- CBNumber
- CB69015454
- Molecular Formula
- C42H54N4O6
- Formula Weight
- 710.9
- MOL File
- 2565656-70-2.mol
3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)- Property
- Boiling point:
- 863.9±60.0 °C(Predicted)
- Density
- 1.234±0.06 g/cm3(Predicted)
- solubility
- PBS (pH 7.2): Slightly Soluble: 0.1-1 mg/ml
- form
- Solid
- pka
- 3.79±0.10(Predicted)
- color
- Off-white to light yellow
- InChIKey
- BRLGERLDHZRETI-BGBFCPIGSA-N
- SMILES
- [C@H]([C@]1([H])CNCC1)(C(=O)O)CC1C=CC=C(C=1)CN(CC1C=CC=C(C=1)C[C@@H]([C@]1([H])CNCC1)C(=O)O)CC1C=CC=C(C=1)C[C@@H]([C@]1([H])CNCC1)C(=O)O
3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)- Chemical Properties,Usage,Production
Uses
Muvalaplin (LY3473329) is an orally active, selective small molecule inhibitor of lipoprotein (a) (Lp (a)) that disrupts the initial non-covalent interaction between apo(a) and apoB100, preventing the disulphide bond and Lp(a) formation. Muvalaplin reduces the levels of Lp (a) in transgenic mice and in cynomolgus monkeys[1][2][3][4][5].
in vivo
Muvalaplin (1-30 mg/kg, p.o., daily for 5 days) reduces the levels of Lp(a) in the Lp (a) transgenic mouse model[3].
Muvalaplin (1-100 mg/kg, p.o., daily for 15 days) reduces the levels of Lp (a) levels in cynomolgus monkeys[3].
| Animal Model: | Lp (a) transgenic mouse model[3] |
| Dosage: | 1-30 mg/kg |
| Administration: | p.o., daily for 5 days |
| Result: | Reduced the levels of Lp(a) with an absolute ED50 of 3?mg/kg. |
| Animal Model: | Cynomolgus monkeys[3] |
| Dosage: | 1-100 mg/kg |
| Administration: | p.o., daily for 15 days |
| Result: | Reduced median Lp(a) levels in a dose-dependent manner by up to 71%. |
References
[1] Bhatia HS, et al. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. J Clin Med. 2022 Oct 13;11(20):6040. DOI:10.3390/jcm11206040
[2] Nicholls SJ, et al. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial. JAMA. 2023 Sep 19;330(11):1042-1053. DOI:10.1001/jama.2023.16503
[3] Diaz N, et al. Discovery of potent small-molecule inhibitors of lipoprotein(a) formation. Nature. 2024 May;629(8013):945-950. DOI:10.1038/s41586-024-07387-z
[4] Hooper AJ, et al. Potential of muvalaplin as a lipoprotein(a) inhibitor. Expert Opin Investig Drugs. 2024 Jan;33(1):5-7. DOI:10.1080/13543784.2024.2302592
[5] Norata GD, et al. Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering. Eur Heart J. 2023 Dec 21;44(48):5018-5020. DOI:10.1093/eurheartj/ehad682
3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)- Preparation Products And Raw materials
Raw materials
Preparation Products
3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)- Suppliers
- Tel
- 010-88886666-01 13112345678
- Fax
- CDXH21@126.com
- loyson@tcypharm.com
- Country
- China
- ProdList
- 597
- Advantage
- 55
- Tel
- 025-83697070 13913916777;
- Fax
- +86-25-83453306
- info@chemlin.com.cn
- Country
- China
- ProdList
- 16083
- Advantage
- 64
- Tel
- 0512-62857507
- Fax
- +86-512-62857507
- sales@sinorarechem.com
- Country
- China
- ProdList
- 998
- Advantage
- 58
- Tel
- 021-11111111 11111111111
- Fax
- qq:546919421
- 546919421@qq.com
- Country
- China
- ProdList
- 3548
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 028-83379370 13880556291
- Fax
- 028-87747383
- tcy@tcypharm.com
- Country
- China
- ProdList
- 7219
- Advantage
- 58
- Tel
- 0550-5196001 15000891977
- Fax
- 0550-5196001
- wj520wjxby@126.com
- Country
- China
- ProdList
- 1944
- Advantage
- 55
- Tel
- 13761310616
- Fax
- QQ: 39324283
- 39324283@qq.com
- Country
- China
- ProdList
- 1424
- Advantage
- 58
- Tel
- 0531-61320525 15866703830
- figo.gao@foxmail.com
- Country
- China
- ProdList
- 5711
- Advantage
- 58
- Tel
- +8615866703830
- figo.gao@foxmail.com
- Country
- China
- ProdList
- 8497
- Advantage
- 58
View Lastest Price from 3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)- manufacturers
- Product
- Muvalaplin 2565656-70-2
- Price
- US $0.00/gram
- Min. Order
- 10gram
- Purity
- 99% min
- Supply Ability
- 20 TONS
- Release date
- 2023-10-24